Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion

J. McCullough, B. J. Weiblen

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Compared to ACD anticoagulant, CPD has the following advantages for blood preservation: (1) isotonicity for red blood cells, thus minimizing the lesion of collection and resulting in improved red blood cell survival, (2) more physiological pH, (3) 15% less citrate ion, and (4) improved red cell oxygen transport. Many blood banks are now beginning the routine use of CPD in blood collections. This should result in an improved blood product for patient therapy.

Original languageEnglish (US)
Pages (from-to)980-982
Number of pages3
JournalMinnesota medicine
Volume56
Issue number11
StatePublished - Dec 1 1973

Fingerprint Dive into the research topics of 'Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion'. Together they form a unique fingerprint.

Cite this